Close menu

June 22nd, 2022 | 13:40 CEST

Nordex, Saturn Oil + Gas, Shell - Reality vs Idealism: Long in oil stocks!

  • Oil
  • Sustainability
  • Investments
Photo credits:

The idea that renewable energies will feed the world's entire energy needs is desirable but unrealistic in the short term. In the political debate in Germany, we are currently seeing how far apart the target images of "green" or "sustainable" and security of supply can be. In an exemplary manner - and this is meant with a wink - Europe's largest economy is shutting down its nuclear power plants and now suddenly realizes that its great dependence on Russia's gas supplies is creating a supply risk. Now a ramp-up of coal-fired power plants is supposed to fix it. For logical and forward-looking investors, oil stocks are worth a look.

time to read: 4 minutes | Author: Carsten Mainitz
ISIN: NORDEX SE O.N. | DE000A0D6554 , Saturn Oil + Gas Inc. | CA80412L8832 , Shell PLC | GB00BP6MXD84

Table of contents:

    Nordex - Share falls like a stone

    The shares of the northern German wind turbine manufacturer are clearly suffering. Although the Company should "actually" be one of the beneficiaries of the energy turnaround, the share price speaks a different language. In the last few days, the share has sunk below EUR 9 and has thus fallen by a third from its high in the spring of 2021.

    The Group's market capitalization is currently around EUR 1.4 billion. The analyst community bravely sticks to its buy recommendations, even if the price targets have been cut. On average, the experts believe that the shares have an upside potential of 73% over the next 12 months. Purposeful optimism? The last profit achieved by the North Germans was in the 2017 financial year, which stood at just EUR 0.3 million.

    The current fiscal year will also be coloured red. The Company has been pointing this out for some time. With the recently published Q1 figures, Nordex has put butter on the fish, which did not go down well with investors. The loss increased by almost EUR 100 million in the first three months to around EUR 151 million. The operating result (EBITDA) before realignment costs was EUR -52 million, compared with EUR +10 million in the previous year. Nordex cited the costs of realigning rotor blade production, lower installation output and increased raw material and logistics costs as reasons for the poor performance.

    "The start to 2022 has been difficult and has certainly gone differently than everyone expected," CEO José Luis Blanco commented on the quarterly figures. He added that there were still "significant supply chain disruptions." Nevertheless, the group leader maintained his medium-term forecast with an operating margin of 8%. For 2022, the wind turbine manufacturer assumes -4 to 0% for this key figure. Given the very weak start to the year, investors would be better off looking at the lower end of the target ranges. Even if a small profit could be generated operationally in the next fiscal year, Nordex will not post a profit until 2024 at the earliest - this is what the analyst consensus suggests.

    Thus, there are currently few aspects on the horizon as to why the stock should end its downward trend soon. The challenging framework conditions were recently joined by homemade problems. Due to a cyber security incident, the Group could not publish its figures on time and, as a result, has to leave the SDAX.

    Saturn Oil & Gas - A completely different league

    Under the leadership of CEO John Jeffrey, the Canadians have achieved extremely impressive growth over the past two years. The goal of becoming a leading publicly traded light oil producer and growing by acquiring and developing undervalued, low-risk projects has now been achieved with the latest acquisition, having already increased production by a factor of 20 with the Viking Assets acquisition last year.

    Saturn announced plans to now acquire additional assets in the Viking area of west-central Saskatchewan for approximately CAD 260 million. This will increase production per day at full capacity by more than half to around 11,400 boe/d. In addition, there will be synergy effects, which will reduce costs.

    To finance the transaction, the Company has already announced the closing of a CAD 75 million bought deal and a planned placement without broker participation of CAD 3 million. The placement price per share is CAD 2.75. In addition, buyers will receive one warrant per two shares with a subscription price of CAD 3.20 and a one-year term.

    Although the stock reacted negatively to the large pending dilution in the short term - the deal is expected to go through in early July - the acquisition makes a lot of sense from a strategic perspective. The big picture with high oil and gas prices and a resulting significant profitability is right. The analysts at GBC believe that the shares have the potential to multiply. The experts at also rate the stock as offering good opportunities.

    Shell - Favorite among the oil multinationals

    The recent slide in oil prices has also dragged down the share prices of oil multinationals such as Shell. Meanwhile, the shares of the British company are rising again, also spurred by positive analyst comments. RBS expert John Musk recently formulated a price target of just under EUR 35 for the stock, corresponding to an upside potential of around 40%. Moreover, according to Musk's rating, Shell is one of the favourites within the sector.

    High commodity prices boost profits in the sector and thus free cash flows. According to analyst estimates, the P/E ratio in this and the next fiscal year is 5 for Shell, and the P/B ratio will drop significantly from the current 1 in the next few years. The dividend yield is expected to rise above 4% in the future.

    In the short and medium-term, there is no way around established energy sources such as oil, gas and coal. Security of supply trumps dogma. Analysts thus recommend oil stocks such as Shell and Saturn for good reason. In the case of the Canadians, investors have the opportunity to profit from an upcoming revaluation. Nordex is an example of how not all companies in the "green energy" sector manage to operate profitably. Watching is better than investing here.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author

    Related comments:

    Commented by Juliane Zielonka on September 29th, 2023 | 07:00 CEST

    Defence Therapeutics, Schott Pharma, Allianz Group: Focus on Innovation, Growth and Portfolio Optimization

    • Biotechnology
    • Pharma
    • Investments

    According to a recent study, biotech company Defence Therapeutics achieves twice the immune response of conventional mRNA therapies with its Accum® mRNA technology. That translates to fewer side effects and a more effective treatment. According to Precedence Research, the market size for mRNA therapeutics is projected to reach approximately USD 137.59 billion by 2032. It is expected to grow at a CAGR of 13.2% from 2023 to 2032. In order to inject these active ingredients, precision-fit medical vials are required, and Schott Pharma is ensuring this with their IPO launched on the German stock exchange this week, which could bring a valuation of around EUR 4 billion. The Allianz Group, on the other hand, is focusing on consolidation, selling its business in the Middle East and thus flushing around EUR 210 million cash into its coffers.


    Commented by Armin Schulz on September 27th, 2023 | 09:05 CEST

    Nikola, Saturn Oil + Gas, BASF - A Buy in difficult times?

    • Mining
    • Oil
    • Batteries
    • renewableenergies
    • chemicals

    These are challenging times on the stock market. Central banks have not announced the end of interest rate hikes, which is poison for growth companies. In addition, extreme weather conditions are affecting the production of some companies, and there are geopolitical tensions to consider, including the ongoing Ukraine conflict and the simmering dispute between the US and China. Recently, there have also been tensions between China and Germany. Following critical statements by Foreign Minister Baerbock to China's Xi Jinping, the German ambassador was summoned. Energy shortages are becoming increasingly significant for many companies in Germany. Today, we look at three companies suffering from the problems described.


    Commented by André Will-Laudien on September 26th, 2023 | 07:45 CEST

    Artificial Intelligence in Sellout! Nvidia, Defense Metals, ARM Holdings - Nothing works without rare earths!

    • Mining
    • RareEarths
    • AI
    • chips
    • Investments

    After long bull market movements, the stock market usually tends to rotate sectors, or the market enters a general consolidation. In the former case, investors can profit by reallocating their assets while exploring new investment opportunities. In the latter case, all stocks come down, and the capital market generally suffers from a change in sentiment and corrects recently exaggerated valuations. In the case of the new megatrend of Artificial Intelligence (AI), the stock market seems to sense a great need for correction. As if by magic, the blockbuster stock Nvidia rose by 250% in just 9 months. However, it has already retraced nearly 20% from its peak. Where do the opportunities lie for investors?